¹ú²ú¾«Æ·

2024 Symposium: Bringing it home... Embracing collective wisdom to grow our future

Symposium Co-Chairs: Prof Sallie Pearson and Dr Jack Janetzki

Previously we have 'bridged the gap between evidence and use' and 'mobilised data to accelerate evidence- generation'; we have learned from colleagues across the globe, and from consumers and policy makers.

As MI-CRE enters its fourth year, it's time to Bring it home...

This year's Annual Symposium held 14-15 August 2024 featured an exciting program of presentations and panel discussions from MI-CRE researchers, including for the first time, two special themed sessions showcasing consumer involvement and research impact.

As always, there was plenty of opportunity to network with friends and colleagues from across the MI-CRE nodes and our external stakeholders.

In keeping with this year's theme, we had two wonderful Keynote Speakers:

  • Prof Andrew Wilson, Chair of the Pharmaceutical Benefits Advisory Committee (2015-2024) and MI-CRE Chief Investigator, who reflected on the role of pharmacoepidemiology in PBAC decision-making.
  • Dr Andrea Schaffer, Epidemiologist, University of Oxford and ¹ú²ú¾«Æ· alumna, who shared her experience working with the OpenSAFELY data analytics platform and the issues of balancing reproducibility and privacy when using real-world data.

On Day 2, we focused on building our science communication skills with a great workshop led by facilitator David Crisante and making plans for the next 12 months in our Portfolio Groups.

Links to the abstracts and recordings of the sessions can be found in the tabs below.

Ìý

Opening and Welcome

Symposium Co-Chairs: Dr Jack Janetzki and Prof Sallie Pearson

Contributions of pharmacoepidemiology to HTA - observations from PBAC 2015-2024

Keynote Speaker: Prof Andrew Wilson

Abstract Session 1a: Consumer involvement stories

Session Co-Chairs: Ms Ainslee Cahill and Mr Steven Marsh

Ximena Camacho, ¹ú²ú¾«Æ· Sydney

Risk of injuries associated with initiation of tapentadol vs oxycodone. Ìý

Nicola Meagher, Daffodil Centre

‘Who is this for?’ Involving consumers in ovarian cancer research.

Abstract Session 1b: Methods

Session Chair: Prof Sallie Pearson

Chrianna Bharat, NDARC ¹ú²ú¾«Æ· Sydney

The use and implementation of instrumental variables in pharmacoepidemiology: A scoping review

Kelly Hall, University of South Australia

Evaluation and extension of the prevalent new-user cohort design: A simulation study

Abstract Session 2a: Pharmacoepi 'pot-pourri'

Session Co-Chairs: Ms Kendal Chidwick and Dr Erin Kelty

Tamara Milder, ¹ú²ú¾«Æ· Sydney

Discontinuation of SGLT2 inhibitors in people with type 2 diabetes following hospitalisation for heart failure: a cause for concern?

Ramya Padmavathy Radha Krishnan, University of Sydney

Cardiometabolic adverse effects associated with prolonged antipsychotic treatment for non-psychotic disorders in children: a systematic review

Jun Ni Ho, University of South Australia

Exploring the use of biologic therapies for paediatric immune-mediated inflammatory diseases in Australia

Adrian Walker, ¹ú²ú¾«Æ· Sydney

Medically assisted reproduction and hormone sensitive cancers in women: Results from the CREATE study

Abstract Session 2b: CNS Medicines and Harms

Session Co-Chairs: Ms Jun Ni Ho and Ms Ramya Padmavathy Radha Krishnan

Craig Cumming, University of Western Australia

Drug dispensing patterns before and after incarceration

Ebony Quintrell, University of Western Australia

Alcohol pharmacotherapy dispensing trends in Australia between 2006 and 2023

Kendal Chidwick, NDARC ¹ú²ú¾«Æ· Sydney

Trends in prescription opioid analgesic use in Australia from 2015 to 2022: perspectives from multiple data sources

Ria Hopkins, NDARC ¹ú²ú¾«Æ· Sydney

Age-related risk of serious fall events associated with opioid analgesic use

Abstract Session 2c: Impact Stories

Session Co-Chairs: Ms Kelly Hall and Dr Michael Falster

Erin Kelty, University of Western Australia

Big pharma, big impact? – The safety of methoxyflurane for emergency pain relief

Lachlan Dalli, Monash University

Impact of the TEN-SPIDERS tool on the reporting of the proportion of days covered method in pharmacoepidemiology research

Jack Janetzki, University of South Australia

Contrary to experts warnings, common antibiotics are not linked to a higher risk of internal bleedingÌý

Laura Gerhardy, University of Sydney

Prescription retinoid and contraception use in women in Australia: getting the message out.

MI-CRE Project Incubator

Session Chair: Dr Chrianna Bharat

Balancing reproducibility and privacy with real-world data: Lessons from OpenSAFELY

Keynote Speaker: Dr Andrea Schaffer

Awards Ceremony

Session Co-Chairs: Prof Nicole Pratt and Dr Chrianna Bharat

Wrap Up - Prof David Henry

Ìý

Please note there are no recordings from our program on Day 2.

Science Communication Workshop

Facilitated by David Crisante

Portfolio meetings
'Minute with a Mentor'
Project and Portfolio updatesÌý

Team activity

ECRs vs Cls - Translate that abstract!

Closing remarks and wrap-up